tocilizumab,rituximab
Roche,JW Pharma
[]
should immunosuppression be used to improve #pah in #ssc added to pah rx (85%) morbidity or mortality outcomes &gt;700 pts - half had a dmard after dx rheumnow #eular2023 op0238 targeted rx improved esp rtx\tcz findings v interesting results #gamechanger may change my rx practice!
not so new at tweeting but always opinionated